Search：
All Dates：
- All
- 2026-06-11 [Thursday]
- 2026-06-12 [Friday]
- 2026-06-13 [Saturday]
- 2026-06-14 [Sunday]
All Rooms：
- All
- A1-A (102-107)
- A1-A101
- A1-A102
- A1-A103
- A1-A104
- A1-A (105-107)
- A1-A108
- A1-A109
- A1-A110
- A2-A206
- A2-A207
- A2-A208
- A2-A213
- A2-A214
- A2-A215
- B1 Hall (Poster Area)
- B1 Hall (Exhibition Area)
2026-06-12 (Friday)
A2-A215
13:00-14:30
| CARES TIME (Hengrui Pharma) Satellite Symposium
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 13:00-13:10 |
Treatment Beyond RECIST Progression: The Art of On-Demand TACE in Triplet Therapy |
Masatoshi Kudo | Kindai University Faculty of Medicine, Japan |
| 2 | 13:10-13:20 |
"Chinese Regimen" Reshapes the First-Line Treatment Landscape for Advanced HCC |
Yuan Cheng | Affiliated Jinling Hospital, Medical School of Nanjing University, China |
| 3 | 13:20-13:30 |
TACE Combined with Immunotherapy and Targeted Therapy：State of the Art |
De-Chao Jiao | The First Affiliated Hospital of Zhengzhou University, China |
| 4 | 13:30-13:55 |
Panel |
A LL | |
| 5 | 13:55-14:05 |
Five-Year Survivors Against the Odds: Camrelizumab Plus Apatinib Enabling Conversion Surgery and Salvage Success in Advanced Hepatocellular Carcinoma |
Jin-Peng Li | Shandong Cancer Hospital and Institute, China |
| 6 | 14:05-14:15 |
Investigator-Initiated Trial：HAIbrave-001 |
Lu-Jun Shen | Sun Yat-sen University Cancer Center, China |
| 7 | 14:15-14:30 |
Panel |
A LL |
